Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583063 · ClinicalTrials.gov registry record · Early Phase 1
Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers
A Early Phase 1 study, sponsored by University of Chicago.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 23
- Enrollment target
NCT00583063: Completed Early Phase 1 study, sponsored by University of Chicago.
NCT00583063 is a Early Phase 1 study that has completed, run by University of Chicago. The registered enrollment target is 23 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00583063, a Early Phase 1 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
Determine the pharmacokinetic interactions between rapamycin and sunitinib in patients with advanced solid tumors.
Interventions
- DRUG rapamycin
- DRUG sunitinib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-04 |
| Phase | Early Phase 1 |
What the finished NCT00583063 record still lists
NCT00583063 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which rapamycin is the first listed.
NCT00583063 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00583063 about?
NCT00583063 is a clinical study titled "Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers". Determine the pharmacokinetic interactions between rapamycin and sunitinib in patients with advanced solid tumors.
What is the current status of trial NCT00583063?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 23 participants. The study started on 2007-10. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00583063?
The interventions under investigation include: rapamycin (DRUG), sunitinib (DRUG).
Who is sponsoring clinical trial NCT00583063?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00583063's enrollment target sits among peer trials
23 1088th of 2000 higher than 898 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia